DK416089A - Heparinfragmenter og -fraktioner med anti-hiv virkning - Google Patents

Heparinfragmenter og -fraktioner med anti-hiv virkning

Info

Publication number
DK416089A
DK416089A DK416089A DK416089A DK416089A DK 416089 A DK416089 A DK 416089A DK 416089 A DK416089 A DK 416089A DK 416089 A DK416089 A DK 416089A DK 416089 A DK416089 A DK 416089A
Authority
DK
Denmark
Prior art keywords
fractions
infragments
health
hiv effect
hiv
Prior art date
Application number
DK416089A
Other languages
English (en)
Other versions
DK416089D0 (da
Inventor
Henricus Carl J Ottenheijm
Franciscus C Den Hollander
Erik Desire A De Clercq
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of DK416089D0 publication Critical patent/DK416089D0/da
Publication of DK416089A publication Critical patent/DK416089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicinal Preparation (AREA)
DK416089A 1988-08-24 1989-08-23 Heparinfragmenter og -fraktioner med anti-hiv virkning DK416089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802087 1988-08-24

Publications (2)

Publication Number Publication Date
DK416089D0 DK416089D0 (da) 1989-08-23
DK416089A true DK416089A (da) 1990-02-25

Family

ID=19852794

Family Applications (1)

Application Number Title Priority Date Filing Date
DK416089A DK416089A (da) 1988-08-24 1989-08-23 Heparinfragmenter og -fraktioner med anti-hiv virkning

Country Status (13)

Country Link
EP (1) EP0355905B1 (da)
JP (1) JPH02108624A (da)
KR (1) KR0143084B1 (da)
AT (1) ATE84217T1 (da)
AU (1) AU617850B2 (da)
CA (1) CA1330305C (da)
DE (1) DE68904264T2 (da)
DK (1) DK416089A (da)
ES (1) ES2053953T3 (da)
IE (1) IE61565B1 (da)
NZ (1) NZ230394A (da)
PT (1) PT91524B (da)
ZA (1) ZA896231B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08109134A (ja) * 1994-10-11 1996-04-30 Sanwa Kagaku Kenkyusho Co Ltd 細胞変成抑制並びに臓器毒性軽減剤
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
EP0735050B1 (en) * 1995-03-31 2002-09-25 Hamilton Civic Hospitals Research Development, Inc. Compositions for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
CA2427757A1 (en) * 2000-11-09 2002-05-16 Contrimmune Biotechnology Inc. Therapeutic uses for ip3 receptor-mediated calcium channel modulators
FR2838649B1 (fr) * 2002-04-19 2006-01-13 Commissariat Energie Atomique Composition anti-vih, procede de fabrication et medicament
US20040229778A1 (en) * 2003-05-13 2004-11-18 Elmaleh David R. Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
WO2011002027A1 (ja) 2009-07-03 2011-01-06 テイ・エス テック株式会社 乗物用シート
ES2535704T3 (es) 2010-09-14 2015-05-14 F. Hoffmann-La Roche Ag Polipéptido de fusión serpina-dedo

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3422518A1 (de) * 1984-06-16 1985-12-19 B. Braun Melsungen Ag, 3508 Melsungen Heparin-derivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung bei der behandlung von fettstoffwechselstoerungen
NZ222695A (en) * 1986-11-29 1990-03-27 Ueno Seiyaku Oyo Kenkyujo Kk Synergistic antiviral compositions
AU4426289A (en) * 1988-10-05 1990-05-01 Nicola Diferrante Methods for interfering with hiv multiplication and composition for the treatment of aids

Also Published As

Publication number Publication date
KR900002788A (ko) 1990-03-23
DE68904264T2 (de) 1993-05-27
AU4001289A (en) 1990-03-01
JPH02108624A (ja) 1990-04-20
PT91524A (pt) 1990-03-08
NZ230394A (en) 1997-02-24
DK416089D0 (da) 1989-08-23
AU617850B2 (en) 1991-12-05
EP0355905A1 (en) 1990-02-28
DE68904264D1 (de) 1993-02-18
IE61565B1 (en) 1994-11-16
ES2053953T3 (es) 1994-08-01
ZA896231B (en) 1990-05-30
IE892565L (en) 1990-02-24
KR0143084B1 (ko) 1998-07-15
ATE84217T1 (de) 1993-01-15
PT91524B (pt) 1995-07-18
CA1330305C (en) 1994-06-21
EP0355905B1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
DK416089D0 (da) Heparinfragmenter og -fraktioner med anti-hiv virkning
TNSN91029A1 (fr) Les analogues du nucleoside de 1,3-oxathiolane
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
NL960024I1 (nl) Farmaceutisch preparaat omvattend 3'-deoxythymidine-2'-een (3'-deoxy-2',3'-didehydrothymidine) voor de behandeling van met retrovirus gesmette patiënten.
MD306B1 (ro) Remediu pentru profilaxia afectiunilor vasculare determinate de actiunea peroxizilor glicoproteinfixati
ZA885577B (en) A pharmaceutical combination product and the preparation and use thereof
EP0311107A3 (en) Anti-hiv active 3'-fluoro-purine-2',3'-dideoxyribosides
DE69023708D1 (de) Anti-hiv-heilmittel.
FI913625A0 (fi) Behandling av nedsatt funktion av leukocyter med gm-csf.
IL88731A0 (en) Non-reverting rna viruses
DE68914990D1 (de) Verfahren zur inhibierung der wirkung des menschlichen immunschwäche-virus (hiv) in vivo.
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
DE3580639D1 (de) Zubereitungen und verfahren zum schutz von t-lymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
ATE211168T1 (de) Assoziation zwischen einem menschlichen immunschwäche-virus verwandten retrovirus und dem sjoegren-syndrom
WO1990005523A3 (en) Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase
IL144382A0 (en) HIV-1 MUTATIONS SELECTED FOR BY β-2',3'-DIDEHYDRO-2',3-DIDEOXY-5-FLUROCYTIDINE
ATE112489T1 (de) Extrakte von acanthospermum hispidum-pflanzen.
ATE64855T1 (de) Zubereitungen und verfahren zum schutz von tlymphozyten gegen das krankheitsagens von lymphadenopathie und vom erworbenen immundepressionsyndrom.
AU2880495A (en) Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
EP1731155A3 (en) Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment